Patient centricity is the process of designing a service or solution around the patient.
To understand the barriers that are preventing companies from achieving patient-centricity, it is important to first define the concept. Although it has become the industry’s tag phrase, it is unlikely that the players are on the same page as to what it actually means to be patient centricity.
The companies must stablish a connection with patients. They need a discussion with patients do anything, for example when write a protocol. It is primordial to receive the patients input in any project, all the time,
While essential for pharma to stay relevant, patient engagement has some limitations. Although patient voice has become important in recent years, it would be outlandish to expect patients to administer all. Patients, while currently given more weight than they used to do, still has a great space to grow.
Unfortunately, another problem is with scientists and doctors, who consider patient input “subjective and non-reproducible,” which, in their eyes, makes it something to be ignored.
Finally, there are difficulties associated with management support. An organization can’t get anywhere without giving support from the top and encouraging all the departments to participate.
Patient centricity seems to be the spirit of modern pharma, and many cultural barriers need to be overcome before it can be fully embraced.